| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 69.59B | 68.67B | 58.54B | 53.75B | 53.23B | 55.20B |
| Gross Profit | 11.14B | 10.84B | 8.79B | 7.70B | 7.71B | 8.84B |
| EBITDA | 7.68B | 8.05B | 5.39B | 4.51B | 4.85B | 5.83B |
| Net Income | 4.94B | 4.73B | 2.77B | 2.14B | 2.40B | 3.28B |
Balance Sheet | ||||||
| Total Assets | 89.74B | 96.70B | 87.32B | 82.85B | 79.86B | 80.62B |
| Cash, Cash Equivalents and Short-Term Investments | 7.77B | 8.31B | 8.91B | 7.85B | 7.84B | 6.76B |
| Total Debt | 3.55B | 2.26B | 2.13B | 1.79B | 1.49B | 1.32B |
| Total Liabilities | 27.64B | 32.97B | 27.54B | 26.07B | 24.35B | 25.98B |
| Stockholders Equity | 62.10B | 63.73B | 59.78B | 56.78B | 55.50B | 54.64B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 309.04M | 1.80B | 1.25B | 1.76B | 1.50B |
| Operating Cash Flow | 0.00 | 2.04B | 3.86B | 2.17B | 2.63B | 3.07B |
| Investing Cash Flow | 0.00 | -1.19B | -1.85B | -830.85M | -455.04M | -1.52B |
| Financing Cash Flow | 0.00 | -1.44B | -960.44M | -1.33B | -1.09B | -2.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥676.50B | 15.50 | 8.07% | 2.85% | 11.18% | -0.75% | |
74 Outperform | ¥63.50B | 9.42 | ― | 2.61% | 10.18% | 38.26% | |
69 Neutral | ¥51.75B | 33.92 | 3.63% | 2.25% | 11.74% | -30.96% | |
67 Neutral | ¥3.94T | 15.03 | ― | 1.41% | 7.73% | -1.93% | |
64 Neutral | ¥164.28B | 29.59 | 5.91% | 2.39% | -3.24% | -25.21% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥58.65B | 59.15 | 0.90% | 4.00% | 0.12% | -105.94% |